The CDXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CDXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CDXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CDXS Detailed Price Forecast - CNN Money||View CDXS Detailed Summary - Google Finance|
|View CDXS Detailed Summary - Yahoo! Finance||View CDXS Stock Research & Analysis - Zacks.com|
|View CDXS Trends & Analysis - Trade-Ideas||View CDXS Major Holders - Barrons|
|View CDXS Call Transcripts - NASDAQ||View CDXS Breaking News & Analysis - Seeking Alpha|
|View CDXS Annual Report - CompanySpotlight.com||View CDXS OTC Short Report - OTCShortReport.com|
|View CDXS Fundamentals - TradeKing||View CDXS SEC Filings - Bar Chart|
|View Historical Prices for CDXS - The WSJ||View Performance/Total Return for CDXS - Morningstar|
|View the Analyst Estimates for CDXS - MarketWatch||View the Earnings History for CDXS - CNBC|
|View the CDXS Earnings - StockMarketWatch||View CDXS Buy or Sell Recommendations - MacroAxis|
|View the CDXS Bullish Patterns - American Bulls||View CDXS Short Pain Metrics - ShortPainBot.com|
|View CDXS Stock Mentions - StockTwits||View CDXS Stock Mentions - PennyStockTweets|
|View CDXS Stock Mentions - Twitter||View CDXS Investment Forum News - Investor Hub|
|View CDXS Stock Mentions - Yahoo! Message Board||View CDXS Stock Mentions - Seeking Alpha|
|View Insider Transactions for CDXS - SECform4.com||View Insider Transactions for CDXS - Insider Cow|
|View CDXS Major Holdings Summary - CNBC||View Insider Disclosure for CDXS - OTC Markets|
|View Insider Transactions for CDXS - Yahoo! Finance||View Institutional Holdings for CDXS - NASDAQ|
|View CDXS Stock Insight & Charts - FinViz.com||View CDXS Investment Charts - StockCharts.com|
|View CDXS Stock Overview & Charts - BarChart||View CDXS User Generated Charts - Trading View|
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
Posted on Wednesday July 11, 2018
Codexis, Inc. (CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development. The appointment brings Dr. Alaoui’s unique drug discovery skills and talents to Codexis at a pivotal time as the company expands its Biotherapeutics business and works to follow recent success in bringing its first drug candidate, CDX-6114 for potential treatment of phenylketonuria (PKU), into early clinical trials.
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
Posted on Monday July 09, 2018
This randomized, double-blind, placebo-controlled Phase 1a trial is intended to evaluate the safety and tolerability of CDX-6114 in up to 32 healthy volunteers, with up to four cohorts receiving a single dose of CDX-6114 at increasingly higher dose levels. Codexis also expects to generate valuable pharmacology data from this study, which will support the future development of the drug candidate.
Free Technical Research on Clovis Oncology and Three More Biotech Equities
Posted on Friday July 06, 2018
LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on CLVS sign up now at www.wallstequities.com/registration. On Thursday, July 05, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. All sectors ended Thursday's trading session in bullish territories.
3 Growth Stocks I'd Buy Right Now
Posted on Thursday June 21, 2018
The world's top lithium producer, a biotech just hitting its stride, and America's top consumer lawn care specialist should be enticing for growth-seeking investors.